Message from Organizing Chairman

“The integration of molecular techniques has enhanced our understanding of cancer etiopathogenesis and also opened new avenues for personalized medicine and targeted therapies, leading to improved patient outcomes.”

Building on the momentum of our efforts and success of FESTOMICS-1 (2025), we are excited to invite you again for: “FESTOMICS-2 (2026)”

Looking forward to your participation in this academic extravaganza.